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Nicotine serves as a feature-positive modulator of Pavlovian 
appetitive conditioning in rats 
M. I. Palmatier, J. L. Peterson, J. L. Wilkinson and R. A. Bevins 
The present experiments examined whether a nicotine 
state could set the occasion for a pairing between visual 
cues and a rewarding outcome in rats. Following nicotine 
administration, presentation of a conditional stimulus (CS; 
light-on) was followed by brief access to a sucrose 
solution. When saline was administered, the same CS was 
presented but was not followed by any consequence. In 
Experiment 1 ,  two groups assessed whether rats could 
acquire this Pavlovian feature-positive discrimination via 
different training procedures. An anticipatory food-seeking 
conditioned response (CR) developed during the 
CS on nicotine sessions but not on saline sessions 
in both groups. In Experiment 2, centrally acting 
antagonists of nicotinic acetylcholine and opiate 
receptors (mecamylamine and naloxone, respectively) 
dose-dependently blocked nicotine's control of the CR, 
whereas the peripherally acting nicotinic antagonist 
hexamethonium had no effect. Increasing or decreasing 
the interval between nicotine administration and testing 
also attenuated the CR. These results are consistent with 
1ntroduc;tion 
Drug discrimination is a widely used animal model for the 
self-reported or subjective effects of drugs in humans 
(Schuster and Jolianson, 1988). One reason for the 
widespread use of this model is that behavior controlled 
by drug states is sensitive to pharmacological mani- 
pulations and reflects drug action at a cellular level 
(Holtzman and Locke, 1988). Traditionally, operant 
conditioning techniques are used to investigate the 
stimulus effects of drugs. In such tasks, the presence 
versus absence of an interoceptive drug stimulus guides 
schedule-maintained behavior. For example, following 
drug administration, a fixed number of responses on a 
lever (e.g. left) may be reinforced by food. Following 
saline administration, a distinctly different lever (e.g. 
right) is reinforced on the same schedule. As a result of 
this trainink the drug cue becomes a discriminative 
stimulus (S ) that guides behavioral output. Thus ,  the 
stimulus effects of the drug set the occasion upon which 
left-lever pressing will be reinforced. Conversely, the  
absence of the  drug effects sets the occasion on which 
right-lever pressing will be reinforced. 
T h e  investigation of drug discriminative stimuli has also 
been extended to aversive Pavlovian conditioning situa- 
tions. This preparation, termed discriminated taste 
aversion, typically involves presenting a flavor conditional 
the hypothesis that nicotine can occasion appetitive 
Pavlovian relations via its action at central nervous 
system cholinergic receptors. Behavioural Pharmacology 
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stimulus (CS) (e.g. saccharin solution) to water-deprived 
rats. When the  flavor is presented in a drug state (e,g. 
morphine; Martin et nl., 1990), i t  is followed by an 
aversive outcome (i.e. lithium chloride injection). In the 
absence of drug, access to the  flavor is not followed by any 
consequence. By the  end of training, rats drink more 
saccharin when morphine is absent than when morphine 
is present. 
T h e  discriminated taste aversion procedure is a useful 
tool for characterizing the behavioral and stimulus effects 
of drugs. However, due to the aversive nature of the 
associations (taste-illness), interpretation and extrapola- 
tion are necessarily contined to avoidance learning 
situations. O n e  question that  has not been answered 
sufficiently is whether the  pharmacological effects of 
drugs can guide Pavlovian conditioned approach behavior. 
T o  our knowledge, two studies (Parker et ad, 1994; Miller 
et al., 2002) represent the only attempts to use a drug 
s ta te  to control appetitive Pavlovian conditioning. In 
these studies, the  pharmacological effects of a drug (i.e. 
methadone) resolved the ambiguity of two keylight 
stimuli. For example, the presence of methadone signaled 
that  illumination of a green keylight was followed by 
access to grain. T h e  absence of methadone signaled that 
grain followed illumination of a white keylight. Even 
though responding was not required to receive grain 
0955-8810 @ 2004 Lippincott Williams & Wilkins DOI: 10.1097/01 .fbp.0000132915.11693.8e 
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access, pigeons pecked more at  the  keylight that was 
followed by grain access in each drug state. 
T h e  fact that only two published studies (Parker et aL, 
1994; Miller et dl., 2002) have examined the cueing 
properties of drugs in Pavlovian approach situations is 
surprising. Many modern theories of drug abuse implicate 
Pavlovian conditioning processes in maintenance and 
relapse of chronic drug use (e.g. Rose and Levin, 1991; 
Robinson and Berridge, 1993; Siegel etal., 2000; Koob and 
LeMoal, 2001). Notably, many of these models concep- 
tualize drugs as outcomes (i.e. behavioral reinforcers or 
unconditional stimuli) paired with purportedly neutral 
environmental stimuli (but see Siegel et nl., 2000). These 
'neutral' environmental stimuli acquire the ability to 
evoke approach behavior as a result of this pairing. 
However, contemporary researchers are beginning to 
examine the interaction between appetitive stimuli and 
drugs of abuse. For example, Caggiula and colleagues 
(Donny et nl., 2003) have demonstrated that non- 
contingent nicotine infusions enhance lever pressing for 
a reinforcing visual stimulus. Other laboratories have 
demonstratcd that nicotine and amphetamine can 
enhance che approach or secking behaviors controlled 
by environmental cues (e.g. tonellight or clicker) that are 
conditional signals for rewarding events (e.g. sucrose 
pellets or water access, see w e l l  and Berridge, 2000, 
2001; Olausson et nl., 2003; 2004a, b). Finally, some 
researchers have demonstrated that drug outcomes can 
be associated with other drug cues that differ in intensity 
and/or pharmacology (e.g. Revusky et dl., 1989; Kim et ad., 
1999). 
Recent worlc from our laboratory reflects a similar 
broadening of the role of Pavlovian conditioning processes 
in drug abuse. For examplc, we recognize that not all 
environmental cues are 'neutral'. In fact, some cues that 
reliably occur with the pharmacological effects of drugs 
will have positive motivational value. If the pharmacolo- 
gical effects of a drug were consistently paired with such 
stimuli, then the drug might acquire the ability to evoke 
approach or investigatory responses (see Alessi et aL, 
2002). Indeed, we have demonstrated recently that 
nicotine serves as a conditional stimulus for access to 
sucrose (Besheer et al., 2004). Briefly, pairing nicotine 
with a rewarding outcome (sucrose access) appeared to 
give nicotine some conditioned excitatory value as 
expressed by anticipatory food-seeking (i.e, goal tracking; 
Farwell and Ayres, 1979). 
T h e  experiments reported here extend our previous work 
by examining whether nicotine can control conditioned 
approach evoked by an environmental cue (i.e. light CS). 
In the nicotine state, this CS was immediately followed 
by sucrose access; no programmed outcome occurred 
when the CS was presented in a saline state. In this 
situation, we conceptualized nicotine as a 'positive 
feature' rather than a Pavlovian conditional stimulus 
(e.g. Bouton and Swartzentruber, 1986; Holland, 1999; 
Rescorla, 1986). That is, nicotine served as a cue that sets 
the occasion on which the light CS will be followed by 
sucrose. Throughout the remainder of this manuscript \ire 
refer to the nicotine cue as a 'feature' of the discrimina- 
tion or a 'modulator' of conditional responding, in order to 
avoid terminologies that might infer behavioral mechan- 
isms (i.e. conditioned facilitator; Rescorla, 1986; or 
Pavlovian occasion setter; Holland, 1983). 
Experiment 1 established that goal tracking developed 
during the light CS, but only in the nicotine state. Follow- 
up tests explored some associative properties of nicotine 
in this situation. For example, we examined whether 
repeatedly presenting nicotine alone (i.e, extinction) 
affected goal tracking when nicotine and the light CS 
were subsequently tested together. In a similar prepara- 
tion, we found that when nicotine was trained as a 
conditional stimulus for sucrose (i.e. no light cues), 
extinction of nicotine attenuated nicotine-evoked goal 
tracking (Besheer et dl., 2004). Experiment 2 examined 
some of the pharmacological properties of the putative 
nicotine modulator. For example, both nicotinic acetyl- 
choline and opiate receptor systems are involved in 
cigarette smoking (e.g. Brauer et nl., 1999) and nicotine 
withdrawal (e.g. Malin ef dl., 1993, 1998). Therefore, we 
examined the effects of nicotinic acetylcholine receptor 
(nAChR) and opiate receptor antagonist pre-treatments 
on the ability of nicotine to occasion goal tracking to the 
light CS. Thus, Experiment 1 explored the behavioral 
conditions under which nicotine-specific goal tracking 
could be established and expressed, while Experiment 2 
began to examine the pl~armacological properties of 
nicotine in the Pavlovian feature-positive paradigm. 
Methods 1 
Subjects 
Eighteen experimentally na'ive male Sprague-Dawley rats 
were obtained from Harlan (Indianapolis, Indiana, USA) 
and housed individually in clear plastic tubs lined I 
with wood-shavings in a temperature- and humidity- 
controlled colony. Water was freely available; however, j 
access to food was restricted, such that the rats were 
maintained at 85% of their free-feeding weight 
(mean = 320 IfI 7 g). This target 85% body weight was 
increased by 2 g every 28 days to follow a typical growth 1 
curve provided by the supplier. Experimental sessions 
were conducted on consecutive days during the  light 
portion of a 12 h 1ight:dark cycle. I 
h 
Apparatus 
Seven standard operant chambers (Med Associates, 
Georgia, Vermont, USA) were housed in a polyvinyl 
chloride sound-attenuating cubicle, fitted with a fan to  
provide airflow and masking noise. Each chamber ' 
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Table 1 Design of Experiment 1 
Group Training I (1 6 sessions) Training 11 (40 sessions) Extinction (6 sessions) Tests 
Pre-training (n=6) Nic:L+ Nic:L+/Sal:L- Nic: - Nic:L-1Sal:L- 
Discrimination (n=5) Nic:L+/Sal:L- Nic:L+ISal:L- Nic: - Nic:L - 1Sal:L - 
Schematic of the procedures used in Experiment 1. Nic: or Sal: indicates that nicotine administration (0.4mglkg base, s.c.) or saline administration (0.90/0, s.c.), 
respectively, preceded the session. L indicates a 30s presentation of light conditional stimulus (CS). + or - indicates access to 26% sucrose or empty interval 
immediately afler each CS, respectively. I indicates separate sessions, which occurred on consecutive days in randomized order for each subject. 
measured 30.5 x 24.1 x 21 cm (I x w x 11); the side walls 
were aluminum and all stimulus elements were attached 
to these walls. T h e  ceiling and remaining walls of the 
chamber were constructed of clear polycarbonate. One 
side of each chamber was fitted with a liquid dipper in a 
receptacle measuring 5.2 x 5.2 x 3.8 cm (1 x w x d). T h e  
dipper arm had a 0.1 ml cup attached for sucrose delivery. 
T h e  receptacle was fitted with an infrared emitter/ 
detector unit, 1.2cm within the tray and 3cm from the 
floor, to monitor head entries into the dipper. Two white 
stilnulus lights (100 rnA, 2.54cm diameter) were 
mounted on thc same wall, 14.6cm above the floor and 
3.5 cm from the nearest perpendicular wall. Illumination 
of these lights served as the CS. T h e  apparatus was not 
fitted with a house light; however, some ambient light 
from the  experimental room reached the closed cubicle 
through the fan and ventilation outlets. A personal 
computer with Med Associates interface and software 
controlled the stimulus events and recorded dipper 
entries throughout each session. 
Drugs 
(-)-Nicotine hydrogen tartrate, hexamethonium sulfate, 
mecamylamine hydrochloride, and naloxone hydrochlor- 
ide (Sigma/RBI, St. Louis, Missouri, USA) were dissolved 
in saline and injected subcutaneously (SC) at a volume of 
1 rnl/kg. Nicotine was brought to a pH of 7.0 _+ 0.2 with a 
dilute NaOH solution. Nicotine doses are expressed as 
the base form. Doses of all other compounds are 
expressed as the salt form. 
Data analyses 
T h e  number of dipper entries was recorded in 30-second 
(Experiment 1) or 15-second (Experiment 2) intervals. 
Dipper entries (i.e. goal tracking) were also recorded 
during the 4 s  sucrose access periods. T h e  main 
dependent measure was the average elevation score for 
each session. An elevation score for each trial was 
calculated from dipper entries that occurred during the 
light C S  minus dipper entries that occurred during an 
equivalent pre-CS period (Brooks and Bouton, 1994). 
Thus ,  an  average elevation score of 0 indicates equal goal 
tracking during the CS and pre-CS periods across a 
session; positive elevation scores indicate more goal 
tracking during CS presentations. Average elevation 
scores were analyzed with one-way or two-way analyses 
of variance (ANOVAs) where appropriate. For pharmaco- 
logical antagonist and temporal generalization tests 
(Experiment 2), a significant one-way ANOVA was 
1 
followed-up by Dunnett's multiple comparisons test, 
contrasting elevation scores from each condition with 
scores from the control condition. When follow-ups 
revealed significant differences, the test conditions were 
compared to a 'no-nicotine' control condition (using 
Bonferroni's error correction) that was derived from 
elevation scores on the  first trial of two saline training 
sessions (see later). Statistical significance was set at 
P I 0.05 (two-tailed). 
Procedures: Experiment 1 
T h e  protocol for each group is presented in Table 1. 
Following dipper training (see later), rats were assigned 
randomly to one of two groups [Pre-training (n = 6) or 
Discrimination (n = 5 ) ] .  Both groups received feature- 
positive discrimination training with nicotine (0.4mglkg) 
as the feature. Different training procedures were 
employed because this experiment was our first attempt 
to establish nicotine-specific goal tracking to a discrete 
CS. For example, we felt that the training procedures in 
the Pre-training group (see later) might facilitate 
acquisition of nicotine-specific goal tracking. T h e  Dis- 
crimination group was included to assess the efficacy of a 
more traditional drug discrimination training regime. T h e  
nicotine training dose was chosen based on robust 
operant performance in previous work (e.g. Chance et 
ul., 1977; Pratt et al., 1983). 
Dipper training 
T h e  first two 50-min sessions were dipper training; rats 
were trained to access 26% sucrose (w/v) within 4s ,  
regardless of their location in the chamber. During the  
first 25 min of the initial session, the cubicle door 
remained open and the  experimenter delivered sucrose, 
For the last 25 min of this session, the cubicle door was 
closed and the computer controlled sucrose deliveries 
using a probability function. T h e  probability of sucrose 
delivery in a 4-s interval started at 0.167, approximately 
2.5 sucrose deliveries/min, and gradually decreased to 
0.133 (2 sucrose deliverieslper min) over the remainder 
of the session. Dipper training continued on the following 
day; however, the probability for sucrose delivery began at 
0.133 and gradually decreased to 0.05 (approximately 0.75 
sucrose deliverieslmin) . 
Pre-training group 
Modulatory training. Nicotine was injected s.c. 5 min 
before each placement in the apparatus for the 
first sixteen 20-min sessions following dipper training 
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(Days 1-16). Each presentation of the  light CS was 
immediately followed by 4 s  access to sucrose. On Days 
17-56, half of the experimental sessions were preceded 
by nicotine administration, the remaining sessions were 
preceded by saline administration. T h e  order in which 
these two session types (Nicotine or Saline) occurred was 
quasi-random across each 8-day cycle, with the constraint 
that the same type of session did not occur on more than 
two consecutive days. Each type of session was equally 
represented within the  cycles. T h e  CS was followed by 
4 s  access to sucrose during nicotine sessions (Nic:L + ); 
CS presentations were not followed by any programmed 
consequence on saline sessions (Sa1:L-). A 4 s  empty 
interval occurred after CS offset in saline sessions, to 
equate data sampling periods and total duration across 
the session types. 
On Days 1-12 there were eight CS presentations per 
session; rats were shifted to four trials per session on Days 
13-16 due to high dipper entrics during the first 12 
sessions. The  number of CS presentations per session was 
then increased to six for the remainder of the training phase 
(Days 17-56). Four Med-State Notation programs were 
used to deliver the stimuli and record dipper entries. T h e  
programs differed in regard to first trial onset (mean = 120 s, 
range = 90-150 s) and the order of inter-trial intervals (ITIs, 
CS offset to next CS onset). For each program, ITIs were 
randomly chosen from a distribution (mean = 154s, 
range = 94-214s); each interval occurred at least once per 
session, with the same interval occurring no more than twice 
in a session. Across an 8-day training cycle each program 
controlled one nicotine session (sucrose delivered) and one 
saline session (sucrose not delivered). 
Extinction atd testing. Six consecutive feature extinction 
sessions followed the acquisition phase (Days 57-62). 
The nicotine feature may 'set the occasion' for respond- 
ing to the light CS. On the other hand, some associative 
models would predict that the nicotine feature enhances 
responding to the light CS because of an excitatory 
association between nicotine and sucrose (e.g. Rescorla 
and Wagner, 1972). Accordingly, for both groups we  
attempted to extinguish any potential goal tracking (i.e. 
conditioned excitation) that was evoked via a nicotine- 
sucrose association. On each of the  six extinction 
sessions, nicotine was injected s.c. 5 min before place- 
ment in the experimentak chamber; the light CS and 
sucrose were not presented (Nic: -) but dipper entries 
were recorded. Two post-extinction test sessions (Days 
63 and 64) followed feature extinction in counter- 
balanced order across subjects. These sessions lasted 
20min and consisted of three presentations of the light 
CS but not sucrose. One session occurred 5 min after 
nicotine administration; the other test occurred 5 rnin 
after saline administration. An equal number of rats 
received nicotine and saline as the first solution tested. 
i Retention and testizg. Following the post-extinction test , 
(Day 64), rats were given free access to food for 30 days. 
On Day 94 each rat was weighed and a new 85% target 
weight was calculated. Food was then restricted such that 
rats reached the new 85% target weight within the next 5 
days (Days 95-99). Days 100 and 101 were retention 
tests, 43 and 44 days from the end of acquisition training, 
respectively. The procedures for these tests were similar 
to the post-extinction tests except nicotine and saline 1' 
were tested in the opposite order for each rat. s 
Discrimination group 
~Wodulatory tmining. For this group, discrimination train- 
ing began on Day 1 (see Table 1). All 56 sessions were 
parametrically identical to those described for the Pre- 1 
training group; however, these rats began training with 
intermixed nicotine and saline sessions. I i 
Extinction, retention, and testing. Feature extinction, post- 4 
extinction, and retention test sessions were identical to 
the Pre-training group. For the post-extinction test three a 
rats were tested with nicotine first; the remaining two 
rats were tested with saline. During the 43-day retention I 
interval, rats were treated similarly to the Pre-training I 
group; testing order of the solutions was reversed for the 
retention tests. I 
Procedures: Experiment 2 
I 
Dipper training 
Dipper training included three 50-min sessions con- 
ducted on consecutive days. All three sessions were I 
entirely computer controlled; the probability function 
decreased from 0.167 to 0.05 per 60s (approximately 2.5 I 
to 0.75 sucrose deliverieslmin) over the three sessions. k 
Modulatory training 
Training for these rats (n = 7) was similar to  the 1 
Discrimination group of Experiment 1, except t h e  CS 
duration was reduced from the 30 s to 15 s and i t  was 
presented eight times in each 20-min training session. 
Prior to testing there were 24 total training sessions in 1 
three 8-day cycles (Days 1-24). 
f 
nAChR antagonist tests 
Initial tests assessed the effects of pre-treatment with 
hexamethonium (HEX, 2.5 or 5 mglkg s.c.), mecamyla- " 
mine (MEC, 0.5 or 1.Omglkg s.c.), or saline (SAL) on Ei 
nicotine-modulated goal tracking. T h e  highest dose of 
mecamylamine is behaviorally effective without non- $ 
specific effects on goal tracking in our laboratory (Besheer 
et al., 2004). During the test phase, training cycles were r 
shifted to 7 days with six training sessions and one test in 
each cycle. A performance criterion (see later) was 
assessed on the last four training sessions of each 
Saline, mecamylamine, and hexamethonium pre- 
ment tests were intermixed in a randomized ord 
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each rat. After completing all test conditions, each rat was 
randomly assigned a new randomized order. Thus, each 
antagonist dose and saline was tested twice for each rat; 
average elevation scores from these two tests were used 
for analyses. T h e  programs controlling test sessions were 
identical to those for saline training sessions, except that 
test sessions ended after 4min and included only one 
presentation of the CS. SAL, MEC, or HEX was 
administered 15 rnin before nicotine (0.4 mglkg) 20 rnin 
before the start of the test session. 
Naloxone tests 
In  subsequent tests, we assessed the effects of naloxone 
(NAL; 0.0, 0.5, 2, 4 or 6mgIkg s.c.) pre-treatment on 
nicotine-modulated goal tracking. Naloxone tests began 
one cycle after rats completed mecamylamine and 
hexamethonium testing. Naloxone was administered 
5 min before nicotine ( i s .  10 rnin before the start of the 
session). All other test parameters were identical to the 
nAChR antagonist tests. 
Temporal delay tests 
Following the  naloxone tests, each rat was tested with 
various temporal delays (0, 5, 25, 50, 100, 125 or 200 min) 
between nicotine administration and the start of the test 
session. After s.c. injection of 0.4mglkg nicotine, rats 
were returned to the home cage for the appropriate delay, 
or were immediately placed in the apparatus (0-min 
condition). T h e  5-min delay test was identical to the 
deiay used in all other training and testing procedures and 
was included as a baseline condition. Two of the longer 
delays (50 and 100 min) were originally included to assess 
t h e  temporal persistence of the nicotine cue. However, 
intervals of 125 and 200 min were added to the previously 
randomized test blocks due to maintained conditioned 
responding at  50 and 100 min. 
Performance criterion 
Each rat in Experiment 2 was required to complete a 
minimum of three 8-day cycles before criterion was 
assessed (i.e. Modulatory Training). To calculate the 
criterion, mean elevation scores were contrasted across 
nicotine and saline sessions for the last training cycle and 
each test cycle. In order to meet the test criterion, 
average elevation scores from nicotine sessions had to be 
a value of 3 greater than average elevation scores from 
saline sessions. A similar contrast was conducted on first- 
trial data from the last nicotine and saline session of each 
cycle. T h e  criterion required a minimum difference score 
of 1 for this first-trial contrast. T h e  criterion elevation 
scores were chosen n priori, based on scores from 
Experiment 1. All rats met the criterion during the last 
cycle of Modulatory Training, rats not meeting both 
criteria during the  test phase remained in the home cage 
during t h e  following test session. 
Results 
Experiment 1 
T h e  different procedures used for groups Pre-training and 
Discrimination resulted in differential exposure to 
nicotine (36 and 28 nicotine injections, respectively), 
different amounts of sucrose access (264 and 192 
deliveries, respectively), and different ratios of reinforced 
to non-reinforced presentations of the CS ( 9 5  and 1:1, 
respectively). Accordingly, data from each group were 
analyzed separately. 
Pre-training group 
ModuIatoory training. Data from the acquisition phase are 
presented in Fig. 1A. T h e  initial one-way repeated 
measures ANOVA revealed a main effect of Session 
[F(15,75) = 8.3, P < 0.0011 on the  first 16 (Nic:L + ) 
sessions. A two-way repeated-measures ANOVA on 
elevation scores from subsequent sessions revealed a 
significant main effect of Drug [F(1,95) = 139.20, 
P < 0.0011 and a significant Drug x Session interaction 
[F(19,95) = 2.67, P < 0.011. The main effect of Session 
was not significant [ F <  11. To assess potential state- 
dependent effects of nicotine (see Discussion), we 
compared first-trial elevation scores from the  first 
nicotine session (Nic:L+ ) and saline session (Sa1:L-) 
of discrimination training. Responding to the light did not 
differ on the first trial of these initial discrimination 
sessions, t < 1 (see inset graph of Fig. 1A). 
Extinction, retention and testing. Dipper entries were 
recorded across each extinction session. The repeated- 
measures ANOVA revealed that the number of dipper 
entries did not change across the extinction phase 
[ F <  11. T h e  average number of dipper entries for this 
group was 50.5 ( k  11.0) on the first session and 57.3 
( ? 12.7) on the last session. Elevation scores from the  
post-extinction test are presented in the left pane1 of Fig. 
1B. T h e  repeated-measures ANOVA revealed significant 
main effects of Drug [F(1,10) = 86.63, P < 0.003 J and 
Trial [F(Z,10) = 8.55, P < 0.011. T h e  Drug x Trial inter- 
action was also significant [F(2,10) = 4.41, P < 0.051, 
denoting a decrease in elevation scores across trials during 
the  nicotine session. Bonferroni's multiple comparisons 
test confirmed this conclusion: elevation scores on the 
nicotine session only differed significantly from the  saline 
session on Trial 1 [t=6.25, P <  0.0011. These within- 
session extinction effects (left panel of Fig. 1B) 
suggested that data from the first trial of the retention I 
tests would be the most informative. As such, only the 
first trial of retention test sessions were included in 
analyses (right panel of fig. 1B). Elevation scores were 
similar across retention test sessions [t < 11. 
Discrimination group 
Modz~Intory tmining. Elevation scores from the  acquisi- 
tion phase are presented in Fig. 2A. The repeated- 
measures ANOVA revealed significant main effects of 
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Fig. l 
(A) Acquisition 
Sessions 
(B) Tests 
Post-extinction test trials Retention test 
A (A) Mean elevation scores (f 1 SEM) across training sessions for the Pre-training group of Experiment 1. Rats received a nicotine injection (0.4 mgl 
kg base S.C.) 5 min prior to 16 training sessions (Days 1-1 6) in which a light conditional stimulus (CS) was followed immediately by 4 s access to 
sucrose unconditional stimulus (US). Across the next 40 days, nicotine and saline sessions were intermixed; on saline sessions the light CS was ) presented but was not followed by sucrose. Nicotine and saline sessions occurred on separate days, but are overlaid in order of occurrence to 
facilitate comparison. The inset graph illustrates first trial elevation scores from the first saline session (session 17) and the 17th nicotine session 
(session 17). (B) Mean elevation scores from each trial of the post-extinction tests (left), and the first trial of the retention tests (right). .k Indicates 
that mean elevation score on nicotine session differs significantly from comparable saline session, P<0.05. 
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Drug [F(1,108) = 9.04, P < 0.051 and Session 
[F(27,108) = 7.40, P < 0.011 and a significant Drug x 
Session interaction [F(27,108) = 6.31, P < 0.011. 
Extilction, refentiotl and testi~g. Dipper entries did not 
change significantly across extinction sessions [ F <  11. 
Average dipper entries were 52.4 ( + 16.1) on the first 
session and 36.8 (+- 5.1) on the last scssion. Elevation 
scores from the post-extinction test are presented in the 
left panel of Fig. 2B. T h e  repeated-measures ANOVA 
revealed significant main effects of Drug [F(1,8) = 38.84, 
P < 0.011 and of Trial [F(2,8) = 8.85, P < 0.011. T h e  
Drug x Trial interaction was also significant [F(2,8) = 5.00, 
P < 0.051, denoting within-session extinction on the 
nicotine test. Bonferroni's multiple comparisons test 
revealed that elevation scores on the nicotine session 
only differed significantly from the saline session on Trial 1 
[f = 5.92, P < 0.0011. Elevation scores from the retention 
test (right panel of Fig. 2B) were significantly higher on 
the nicotine session than the saline session for this group 
[t(4) = 2.91, P < 0.051. 
Experiment 2 
Modulatory training 
Data from the acquisition phase are presented in Fig. 3A. 
T h e  repeated-measures ANOVA revealed significant 
main effects of Drug [F(1,66) = 72.29, P < 0.0011 and 
Session [F(11,66) = 6.73, P < 0.0011, as well as a 
significant Drug x Session interaction [F( l  l,66) = 8.96, 
P < 0.001]. 
nAChR antagonist tests 
Elevation scores from the nAChR antagonist tests are 
presented in Fig. 3B. T h e  one-way repeated-measures 
ANOVA was significant [F(4,34) = 7.19, P < 0.0011; 
follow-up comparisons revealed lower elevation scores in 
the mecamylamine pre-treatment conditions (0.5 and 
I mg/kg), relative to saline pre-treatment [Ps < 0.051. 
Hexamethonium did not affect elevation scores 
[Ps > 0.051. Elevation scores from the mecamylamine 
pre-treatment tests were compared to a 'no-nicotine' 
baseline for further characterization. This no-nicotine 
baseline was derived from the first-trial elevation scores 
of saline training sessions that immediately preceded 
1 mglkg mecamylamine tests. Pre-treatment with 0.5 mg/ 
Irg mecamylamine yielded significantly higher elevation 
scores than the no-nicotine control [ P  < 0.0011, Elevation 
scores after 1 mg/kg mecamylamine pre-treatment were 
statistically similar to this control [P > 0.051. 
Naloxone tests 
Elevation scores from the naloxone tests are presented in 
Fig. 3C. T h e  one-way repeated-measures ANOVA was 
significant [F(4,34) = 12.04, P < 0.0011, with all doses of 
naloxone significantly decreasing elevation scores 
[Ps < 0.051. Another no-nicotine control condition was 
derived from the first-trial elevation scores of saline 
training sessions that immediately preceded the 6 mg/kg 
naloxone tests. Elevation scores from the 0.5 mg/kg 
naloxone pre-treatment test were higher than the no- 
nicotine condition [ P  < 0.051. T h e  remaining naloxonc 
pre-treatment doses (2, 4 and 6 mg/kg) yielded similar 
elevation scores to the no-nicotine control condition 
[Ps > 0.051. 
Temporal delay tests 
Data from the temporal effect tests are presented in 
Fig. 3D. T h e  one-way repeated-measures ANOVA was 
significant [F(6,48) = 22.06, P < 0.0011; follow-up tests 
revealed that elevation scores from the 25- and 50-min 
tests were similar to those of the 5-min condition 
[Ps > 0.051. In all other test conditions, elevation scores 
differed significantly from the 5-min condition 
[Ps < 0.011. Elevation scores from the 100- and 125-min 
tests differed significantly from a no-nicotine control 
condition [Ps 5 0.0011, derived from first-trial elevation 
scores of the saline training sessions that preceded 5-mi11 
delay tests. The  0-min and 200-min test conditions did 
not differ from this control [Ps 2 0.051. 
Discussion 
T h e  pharmacological effccts of nicotine signaled when a 
light CS would be followed by sucrose, Accordingly, rats 
engaged in more food-seeking behaviors (i.e, goal 
tracking) during the light when nicotine was present 
than when nicotine was absent. This 'modulatory' con- 
trol by nicotine developed whether training began with 
16 consecutive Nic:L+ sessions or with intermixed 
Nic:L + and Sal:L- sessions (Experiment 1). Notably, 
nicotine-specific goal tracking in the Discrimination 
group seemed to be more variable relative to the Pre- 
training group. At first glance, this difference might be 
attributed to the different training parameters. However, 
in Experiment 2 the training procedures were similar to 
the Discrimination group but resulted in much less 
variability. Perhaps more variability in the Discrimination 
group was due to a longer CS duratiol~ (30s in 
Experiment 1 versus 15 s in Experimellt 2) or to the 
smaller sample size in this group (12 = 5); nevertheless, 
further research will be required to determine the source 
of this variability. Experiment 2 extended the nicotine- 
specific goal tracking finding to a shorter CS duration (i.e. 
15 s) and began to elucidate neuropharmacological 
mechanisms. To our knowledge, these experiments are 
the first to investigate the behavioral and neuropharma- 
cological properties of a positive nicotine feature in an 
appetitive Pavlovian conditioning preparation in rats. 
Such a preparation could be an important tool for 
examining the associative and stimulus propertiev of 
drugs, given our demonstration of rapid acquisition and 
stable rates of behavior over a prolonged period of time 
(e.g. Experiment 2). 
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Fig. 2 
(A) Acquisition 
Sessions 
(6) Tests 
Post-extinction test trials Retention test 
(A) Mean elevation scores (* 1 SEM) across training sessions for the Discrimination group of Experiment 1. For this group, training wa 
that of the Pre-training group (see Fig. 11, except that all nicotine and saline sessions were intermixed. Nicotine and saline sessions 
separate days, but are overlaid in order of occurrence to facilitate comparison. (B) Mean elevation scores for each trial of the post-ext 
(left), and the first trial of each retention test (right). 7t Indicates that mean elevation score on nicotine session differs significantly 
session, P<0.05. 
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Fig. 3 
(A) Acquisition (B) Hexamethonium and mecamylamine tests 
I :; l 
SAL 2.5 5.0 0.5 0.5 
Hex Hex Mec Mec 
Sessions Drug pretreatment dose (mglkg) and compound 
(C) Naloxone tests (D) Delay tests 
I '. I 
SAL 0.50 2.00 4.00 6.00 NO-NIC 0 5 25 50 100 125 200 NO-NIC 
Naloxone pretreatment dose (mglkg) Injection to session delay (min) 
(A) Mean elevation scores (f 1 SEM) across training sessions for rats in Experiment 2. For these rats, training was similar to the Discrimination 
group from Experiment 1 (see Fig. 2) ;  all rats met the performance criterion by Session 24 and testing began on Session 26. Mean elevation scores 
on (B) nicotinic acetylcholine receptor (nAChR) antagonist pre-treatment tests, (C) naloxone pre-treatment tests, and (D) temporal delay tests are 
shown. # Indicates drug pre-treatment or delay condition was significantly different from saline pre-treatment or 5-min delay controls, respectively, 
P<0.05; +, indicates drug pre-treatment or delay test condition differs significantly from no-nicotine control condition, P<0.05. 
In order to fully appreciate the associative and stimulus 
properties of nicotine in this preparation, we must 
examine the means by which nicotine controls goal 
tracking. Possibly, the pharmacological effects of nicotine 
provide a stimulus context that modulates a light-sucrose 
relation (e.g. Bouton and Swartzentruber, 1986). Alter- 
natively, a state-dependent learning account suggests that 
the association between the light and sucrose is not 
readily recalled and/or performed outside of the nicotine 
drug-state (e.g. Cunningham, 1979). Our enthusiasm for 
this state-dependence account is diminished by some of 
the results from the Pre-training group in Experiment 1. 
During the initial nicotine training sessions (Nic:L -I- ), 
elevation scores for this group increased steadily, 
suggesting that an association developed between the 
light CS and the sucrose unconditional stimulus (US). 
, Because of the training protocol, rats in the Pre-training 
group may have acquired a nicotine-dependent associa- 
tion. If so, goal tracking to the light CS should be  
disrupted by removal of the nicotine state. However, goal 
tracking in the no-drug state did not differ from goal 
tracking in the nicotine state (see inset graph of Eg. lA), 
suggesting that the light-sucrose association was not 
dependent on the nicotine state. 
Another alternative to the modulatory account is based on 
the perfect correlation between sucrose delivery and the 
nicotine state. Arguably, higher elevation scores on 
nicotine sessions could be the result of conditioned 
excitation evoked by nicotine (e.g. Besheer e t  a l ,  2004) 
summating with weak excitation evoked by the light CS 
( i s .  50% pairing with sucrose delivery). To test  this 
account, we repeatedly presented the putative condi- 
tioned excitor (nicotine) in the absence of the  sucrose 
US. Arguably, this treatment should have reduced the  
ability of nicotine to evoke a conditional response (i.e. 
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extinction; Pavlov, 1927). However, nicotine still con- 
trolled goal tracking during the light CS, despite 120 min 
of extinction treatment. These data provide preliminary 
evidence that goal tracking to the light CS was 
independent of a direct association between nicotine 
and sucrose. However, we must stress the use of the word 
'preliminary'. For example, relative ro the training phase 
(56 sessions) the extinction phase (six sessions) was 
short. Regardless, this preliminary result is encouraging 
and we are currently conducting a more complete analysis 
of nicotine feature extinction. 
One reason for the brevity of the extinction phase was our 
concern about the sensitivity of this task to the passage of 
time. Since this was the  first study of its type in rodents, 
we had no way of knowing how the passage of time might 
affect performance. Extensive feature extinction might 
disrupt modulatory co~ltrol by attenuating the conditional 
stimulus properties of nicotine (Pavlov, 1927; Besheer et 
nl., 2004). Alternatively, a long interval between training 
and testing could affect performance due to decay of 
associative networks involving nicotine, light CS, and 
sucrose over time (e.g. forgetting; Bouton, 1994). From 
this perspective, an important additional test of this 
preparation was to examine performance after a long 
retention interval (i.e. G weeks). O n  the  retention test, 
the Discrimination group exhibited more goal tracking to  
the light during the nicotine session, indicating that t h e  
extinction treatment, post-extinction test, and long 
retention interval did not disrupt the ability of nicotine 
to occasion the goal tracking CR. 
For the Pre-training group, the retention test did not 
reveal differential goal tracking across nicotine and saline 
drug states. This failure resulted from high levels of goal 
tracking during the light on both nicotine and saline test  
sessions (see right panel of Fig. 1B). This  type of 
retention failure would occur if the first association 
(L + ) was better retained than tlie subsequcnt associa- 
tion (L-; e.g. Bouton et czd, 1999). Recall that the light 
CS was initially paired with sucrose on every trial for the  
Pre-training group, but not for the Discrimination group. 
Moreover, for the Pre-training group, the light CS- 
sucrose US association was independent of the nicotine 
state. Accordingly, a retention test might be most 
sensitive to initial learning, which would be  expressed 
as nicotine-independent goal tracking for the Pre-training 
group. Although this account fits the data rather well, 
alternatives sucli as differential sensitivity to the feature 
extinction and/or post-extinction tests cannot be elimi- 
nated at  present. 
Coen, 1989), discriminative sti~nulus (Stolerman et  a/., 
1984), and avoidance learning (Kumar etnl., 1983) effects 
of nicotine. However, nAChR antagonists that do not pass 
the blood-brain barrier (e.g. hexametl~onium) do nor 
impact these effects of nicotine (Kumar et nl., 1983; 
Stolerman et nl., 1984; Corrigall and Coen, 1989). In  
Experiment 2, the ability of nicotine to serve as a 
modulatory cue was dose-dependently attenuated by 
mecamylamine pre-treatment, but not by hexametho- 
nium. This pattern is consistent with previous reports 
that the discriminative stimulus effects (e.g. Stolerman d 
dl., 1984) as well as the conditional stimulus properties 
(Besheer etnl., 2004) of nicotine are mediated by central 
nAChRs. 
Naloxone also attenuated goal tracking occasioned by 
nicotine in a dose-dependent manner. One reason for this 
attenuation could be that antagonism of opioid receptors 
decrements some of the 'downstream' effects of nicotine, 
For example, stimulation of nicotinic receptors results in 
the release of endogenous opioids (e.g. Hexum and 
Russet, 1987); presumably naloxone administration would 
antagonize the effects of this opioid release. Also, 
nicotine-induced dopamine release in the nucleus 
accumbens is attenuated by pre-treatment with naloxone 
(Tanda and DiChiara, 1998). Blocking these opiate- 
related downstream effects of nicotine could attenuate 
some aspect (e.g, salience) of the nicotine stimulus. 
Notably, the doses of naloxone that antagonized nicotine- 
specific goal tracking were mucli higher than those used 
to block the effects of morphine and other prototypical 
mu opioid agonists (e.g. 0.1 mgllrg; Stolerman etnl., 2002). 
Perhaps attenuation of nicotine-specific goal tracking was 
due to antagonism at both mu and delta opiate receptors 
(e.g. Takemori and Portoghese, 1984; Tiseo and Yaksh, 
1993). Activation of kappa opioid receptors via selective 
agonists attenuates the effects of nicotine in the central 
nervous system (e,g. Oka et nl., 1998; Maisonneuve and 
Glick, 1999; Hahn et nl., 2000). Therefore, decrement of 
nicotine-specific goal tracking was probably not the result 
of naloxone antagonism at kappa receptors. On the other 
hand, naloxone, which produces a perceptible interocep- 
tive stimulus on its own (e.g. Smurthwaite et ul., 1992), 
may have attenuated goal tracking via generalization 
decrement (Pavlov, 1927). Pre-treatments with naloxone 
(especially at higher doses) could make interoceptive 
nicotine cues dissimilar from the originally trained 
modulator. This difference between interoceptive cues 
would result in a loss of goal tracking controlled by 
nicotine. Distinguishing between these alternatives will 
require further investigation. 
In  Experiment 2, changing the time between nicotine 
Many of the behavioral effects of nicotine rely on its injection and the start of the experimental sessions r 
action a t  central nervous system nAChRs. For example, altered the ability of nicotine to control goal tracking to 
nAChR antagonists that pass the  blood-brain barrier (e.g. tlie light CS. T h e  effects of varying the  interval between 
mecamylamine) attenuate the reinforcing (Corrigall and nicotine injections and test sessions are consistent with 
b 
Nicot ine m o d u l a t e d  Pavlovian appet i t ive condit ioning Palmatier et a/. 193 
evidence from previous studies on the behavioral and 
physiological time course of nicotine (Pratt et nl., 1983; 
Ghosheh ef Q/., 1999). For example, a loss of goal tracking 
on the 0-min test indicates that nicotinc had not 
accumulated to sufficient plasma and brain concentra- 
tions to produce the stimulus that occasioned goal 
tracking (see Pratt p t  rzL, 1983). T h e  attenuation of goal 
tracking from 100 to ZOO min likely reflects significant 
decreases in the plasma and brain concentrations of 
nicotine over similar intervals (Ghosheh et nL, 1999; 
Pratt et al., 1983). For example, in an operant nicotinc 
(0.4mglkg base, LC.) discrimination using male hooded 
rats, nicotine-appropriate responding peaked from 2.5 
to 10 min post-injection and reached saline levels by 
160min (Pratt et al., 1983). In the same study, plasma 
nicotine concentration peaked between 2.5 and 10 
min post-injection and declined considerably by 
160 min. Using male Sprague-Dawley rats, Ghosheh et nlI 
(1999) determined that  brain concentrations of nicotine 
(0.8 mglkg base, s.c.) peaked at approximately 5 min post- 
injection and declined significantly between 60 and 
240min; the brain half-life of nicotine was determined 
to be approximately 52 min. 
These data represent an important extension of previous 
investigations of drug-modulated Pavlovian conditioning 
(e.g. Miller e t  nl., 2002; Skinner et n/I, 1998). Establishing 
that an appetitive Pavlovian CR can be modulated by 
nicotine in rodents will facilitate future investigation of 
the associative and stimulus properties of nicotine. Given 
that our findings are generally comparable with operant 
nicotine discriminations (e.g. Pratt et al., 1983; Stolerman 
et al., 1984), this model might also be well suited for 
examining the neurobiological substrates of the subjec- 
tive effects of nicotine. Current research in our laboratory 
is extending these modulatory properties of nicotine to 
other drug states, including amphetamine (1.0 mglkg) 
and clllordiazepoxide (5.0 mgllrg), suggesting chat this 
preparation may be an efficient and informative way to 
investigate the subjective effects of drugs in general. At 
minimum, examining the ability of a drug state to control 
conditioned approach will complement our understand- 
ing of its ability to control conditioned avoidance (e.g. 
Martin et nl., 1990) and sclredule-controlled behavior (e.g. 
Pratt et nl., 1983). 
Further investigations that reveal the associative mechan- 
isms by which drug modulators operate will inform 
theories of drug abuse, and might also contribute to our 
understanding of basic Pavlovian conditioning processes. 
One notable extension of the current studies will be to 
examine whether nicotine can serve as a 'negative 
feature'. That  is, if sucrose followed the discrete CS in 
, the saline state but not in the nicotine state, would the 
nicotine cue set the occasion for withholding the goal 
tracking CR? Such experiments are currently under way 
in our laboratory, and the answer appears to be 
affirmative. One question that we have not answered is 
whcther such a training protocol could establish the  
nicotine cue as a conditioned inhibitor (e.g. Pavlov, 1927). 
Indeed, the ~licotine feature has both a serial and 
simultaneous relationship with the light CS. Holland 
and Lamarre (1984) found that negative features 
presented in simultaneous compound with a CS serve 
as conditioned inhibitors, whereas negative features 
presented in serial compound with the CS occasion less 
conditional responding through some other mechanism. 
Therefore, the associative and pharmacological mechan- 
isms by which a contextual cue such as nicotine occasions 
the absence of goal tracking might be  considerably 
different from the manner in which nicotine occasions 
conditioned approach. Accordingly, research comparing 
the behavioral and pharmacological processes underlying 
the ability of nicotine to serve as a positive versus 
ncgative feature is needed. Other studies might exanline 
whether drug stimuli can occasion relationslrips between 
environmental cues and drug outcomes. More specifically, 
could the interoceptive effects of alcohol occasion a 
relationship between the smell of smoke and nicotine 
delivery? Do drug contexts function similarly to other 
Pavlovian occasion setters (e.g. Holland, 1999)? That  is, 
would a drug state that occasions conditioned approach 
with one  CS transfer that control to another similarly 
trained CS (cf. Parker etnl., 1994)? Do drug stimuli servc 
as Pavlovian occasion setters in humans, and are these 
drug contexts involved in maintaining drug use, relapse, 
and/or polydrug abuse? These questions about drug 
stimulus 'contexts' and their role ill Pavlovian or 
stimulus-outcome associations delineate an important 
and exciting avenue for future research. 
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